Tokyo IPO

Japanese

Kohjin Bio Co.,Ltd.

Code Sector Market
177A Chemicals Growth
Date of listing approval 2024/03/22
Expected Date 2024/04/25
Lead Underwriter Nomura    
Description  
Listed Shares(total) 977,500
Trading Unit 100
New Shares 850,000
Existing Shares 127,500¡Êonly O.A.¡Ë
Shares Outstanding PreIPO 4,165,000.00
PostIPO 5,015,000.00
Paid Up Capital PreIPO Y426,656,000
PostIPO Y1,169,556,000
Expected Pricing Date 2024/04/05
Book Building Start 2024/04/09
Book Building End 2024/04/15
Fix Date 2024/04/16
Offering Starts 2024/04/17
Offering Ends 2024/04/22
Expect Pricing Y1,840-Y1,900
Notional PER
(based on previous period)
9.24-9.54
Notional PER(based on results forecast) 26.50-27.37
Offering Price Y1,900
Offering Price PER
(based on previous period)
26.50-27.37
Offering Price PBR
(based on previous period)
2.62
Offering Price PER
(based on results forecast)
27.37
Use of Funds Raised  

Financial Data

Units:Y1,000

Fiscal Year End:2021/03
Consolidated Non-consolidated
Revenue - 3,251,321
Current Profit - 665,762
Net Profit - 685,074
Net Assets - 1,418,904
Fiscal Year End:2022/03
Consolidated Non-consolidated
Revenue 3,947,089 3,622,295
Current Profit 917,837 841,840
Net Profit 587,675 564,269
Net Assets 2,216,895 2,002,942
Fiscal Year End:2023/03
Consolidated Non-consolidated
Revenue 4,742,992 4,406,871
Current Profit 1,244,391 1,116,671
Net Profit 829,790 751,221
Net Assets 3,017,830 2,712,308
Recent Quarter
2023/12
Consolidated Non-consolidated
Revenue 3,544,575 -
Current Profit 397,839 -
Net Profit 207,138 -
Net Assets 3,184,261 -
Results Forecast
2024/03
Consolidated Non-consolidated
Revenue 4,724,000 -
Current Profit 560,000 -
Net Profit 289,000 -
Net Assets - -

Per Share Units:Y1

Fiscal Year End:2021/03
Consolidated Non-consolidated
Dividend 10.00
Net Earning - -
Equity 202.39 412.20
Fiscal Year End:2022/03
Consolidated Non-consolidated
Dividend 10.00
Net Earning 173.50 532.27
Equity 166.59 480.90
Fiscal Year End:2023/03
Consolidated Non-consolidated
Dividend 19.00
Net Earning 199.23 724.57
Equity 180.37 651.21
Fiscal Year End:Recent Quarter
2023/12
Consolidated Non-consolidated
Dividend
Net Earning 49.73 -
Equity - -
Fiscal Year End:Results Forecast
2024/03
Consolidated Non-consolidated
Dividend 14.00
Net Earning 69.43 -
Equity - -

Comment

¢£Over allotment(127,500)

Consolidated Subsidiaries

Name Address

Underwriters

Allocation Underwriter Tel
0% Nomura 03-3211-1811
90% Nomura 03-3211-1811
3% Mizuho 03-5208-3210
3% SMBC Nikko 03-5644-3111
3% Musashi Securities Co.,Ltd 048-644-0634
1% SBI SECURITIES Co.,Ltd. 03-5562-7210

Data

Date of incorporation 1981/04/20
Company address  Saitama 350-0214
Telephone 049-284-3781
President  
Homepage https://kohjin-bio.jp/
Auditor Azsa
Major Shareholders
Shareholder Name Ratio
86.62%
  53.05%
  10.00%
  6.48%
  4.23%
  3.36%
  2.88%
  2.40%
  2.40%
  2.40%
  1.92%
Number of Employees 133 as of 2024/02/29
Birth Date of Representative 1949/05/23

Comment